Evidence map›Paper›PMID 38835088›Full record

ArticleChinese neurosurgical journal2024

Clinical characteristics and treatment strategies for pituitary adenoma associated with intracranial aneurysm.

Zheng Huang, Zeng Yang, Lixin Xu, Haibin Leng, Kui Yang, Wei Ding, Bo Xie, Fenghua Chen, Zhixiong Liu, Zhenyan Li

Abstract read
In one paragraph

Article in Chinese neurosurgical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zheng Huang *Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zeng Yang *Department of Neurosurgery, The First People's Hospital of Changde City, Changde, 415003, China.
Lixin XuDepartment of Neurosurgery, The First People's Hospital of Changde City, Changde, 415003, China.
Haibin LengDepartment of Neurosurgery, The First People's Hospital of Changde City, Changde, 415003, China.
Kui YangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Wei DingDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Bo XieDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Fenghua ChenDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhixiong LiuDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhenyan LiDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China. lizhenyan@csu.edu.cn.

Funding

Hunan Province Science and Technology Innovation Key Project 2020SK1012National Natural Science Foundation of China 81873635National Natural Science Foundation of China 81873756National Natural Science Foundation of China 82001274Natural Science Foundation of Hunan Province of China 2018JJ6139
6 · The paper itself

Abstract

backgroundThis study aimed to investigate clinical features and treatment strategies for intracranial aneurysm (IA) associated with pituitary adenoma (PA).

methodsWe enrolled patients with lesions in the sellar region and age-matched general population who were confirmed with IA from two hospitals. Four types of treatment strategies were performed, which included Type I (both IA and PA were treated with surgery), Type II (IA was treated with surgery and PA was performed by non-surgical treatment), Type III (PA was performed with surgery and observation was available for IA) and Type IV (both IA and PA were performed with non-surgical treatment).

resultsThe incidence of IA was 2.2% in the general population, 6.1% in patients with PA, 4.3% in patients with Rathke cleft cyst, 2.8% in patients with meningioma and none were found with IA in patients with craniopharyngioma. Age over 50 years (OR, 2.69; 95% CI, 1.20-6.04; P = 0.016), female (OR, 3.83, P = 0.003), and invasive tumor (OR, 3.26, P = 0.003) were associated with a higher incidence of IA in patients with PA. During the mean follow-up of 49.2 months, no patients experienced stroke, and recurrence of aneurysms and aneurysms treated with observation were stable. Of four patients with recurrence of PA, three patients were treated for type I and one patient for type III.

conclusionsPreoperative evaluation for aneurysm screening is necessary due to the high incidence of IA in PA patients. Our current treatment strategies may provide a benefit for these patients.

Indexed as

Pituitary adenoma; Intracranial aneurysm; Treatment strategy

Identifiers

PMID38835088
PMCPMC11149326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.